Kuros Biosciences AG (0RHR.L)

CHF 20.55

(1.23%)

Annual Balance Sheets

(In CHF)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 75.9 Million 82.94 Million 91.33 Million 94.36 Million 87.85 Million 85.82 Million
Total Current Assets 27.19 Million 31.39 Million 32.89 Million 33.96 Million 23.29 Million 19.83 Million
Cash And Short Term Investments 14.2 Million 24.06 Million 28.62 Million 28.38 Million 20.8 Million 18.33 Million
Cash and Cash Equivalents 14.2 Million 24.06 Million 28.62 Million 28.38 Million 20.8 Million 18.33 Million
Short Term Investments - - - - - -
Net Receivables 7.61 Million 3.61 Million 2.04 Million 3.57 Million 1.07 Million 214 Thousand
Inventory 4.85 Million 3.17 Million 1.75 Million 1.46 Million 954 Thousand 547 Thousand
Other Current Assets 513 Thousand 540 Thousand 465 Thousand 547 Thousand 459 Thousand 325 Thousand
Total Non-Current Assets 48.71 Million 51.55 Million 58.44 Million 60.39 Million 64.56 Million 65.98 Million
Net PPE 2.64 Million 2.32 Million 2.44 Million 2.58 Million 2.78 Million 634 Thousand
Good Will And Intangible Assets 40.97 Million 48.72 Million 55.99 Million 57.51 Million 61.78 Million 65.35 Million
Good Will 24.46 Million 29.31 Million 33.39 Million 33.84 Million 33.86 Million 34.24 Million
Intangible Assets 16.5 Million 19.41 Million 22.6 Million 23.66 Million 27.92 Million 31.11 Million
Long-Term Investments - 51.04 Million 53.46 Million 60.1 Million 62.52 Million -
Tax Assets 5.07 Million 504 Thousand 4.98 Million 295 Thousand 2.03 Million 1.81 Million
Other Non Current Assets 14 Thousand -51.04 Million -58.44 Million -60.1 Million -64.56 Million -1.81 Million
Other Assets - - - - - -
Total Liabilities 19.19 Million 14.08 Million 14.36 Million 9.76 Million 9.99 Million 9.33 Million
Total Current Liabilities 13.18 Million 12.58 Million 11.28 Million 3.87 Million 3.64 Million 4.04 Million
Account Payables 1.3 Million 1.3 Million 846 Thousand 936 Thousand 1.05 Million 1.61 Million
Tax Payables - - - - - -
Short Term Debt 3.95 Million 416 Thousand 317 Thousand 278 Thousand 246 Thousand -
Deferred Revenue - - - - - -
Other Current Liabilities 7.93 Million 10.87 Million 10.12 Million 2.66 Million 2.33 Million 2.42 Million
Total Non Current Liabilities 6 Million 1.49 Million 3.07 Million 5.88 Million 6.35 Million 5.29 Million
Long-Term Debt 1.56 Million 1.49 Million 1.82 Million 2.06 Million 2.14 Million -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - -5.07 Million 353 Thousand 587 Thousand 727 Thousand 961 Thousand
Other Liabilities - - - - - -
Total Equity 56.71 Million 68.86 Million 76.97 Million 84.6 Million 77.85 Million 76.48 Million
Stock Holders Equity 56.71 Million 68.86 Million 76.97 Million 84.6 Million 77.85 Million 76.48 Million
Common Stock 3.67 Million 3.65 Million 3.28 Million 32.81 Million 22.47 Million 15.05 Million
Retained Earnings -42.15 Million -116.25 Million -101.16 Million -93.15 Million -81.9 Million -69.43 Million
Accumulated other comprehensive income 21.88 Million 20.89 Million 20.7 Million 21.01 Million 20.05 Million 20.51 Million
Common Stock Equity 56.71 Million 68.86 Million 76.97 Million 84.6 Million 77.85 Million 76.48 Million
Capital Lease Obligation 1.56 Million 1.91 Million 2.14 Million 2.34 Million 2.38 Million -
Total Investments - 51.04 Million 53.46 Million 60.1 Million 62.52 Million -
Total Debt 5.51 Million 1.91 Million 2.14 Million 2.34 Million 2.38 Million -
Net Debt -8.69 Million -22.15 Million -26.47 Million -26.04 Million -18.41 Million -18.33 Million

Balance Sheet Charts